"Revenue was $83.8M in the most recent quarter (ended 2025-12-31), while net income was -$95.3M and EPS was $1.54. Net margin is deeply negative based on these results, indicating significant earnings pressure (potentially driven by non-operating items, restructuring, or impairment—details not provided in the dataset). Cash flow was solid at $65.9M of operating cash flow, but capital expenditure of -$71.0M left free cash flow (FCF) at -$5.1M, suggesting heavy investment requirements or timing effects. Balance sheet leverage appears moderate with net debt of $3.1M (near net cash) and equity of $130.2M against $944.5M of assets and $552.5M of liabilities. The shares have had weak overall momentum, down -62.1% over 1 year, which outweighs modest recent strength (+2.0% over 6 months and +10.9% YTD). Valuation inputs are limited (no P/E or FCF yield provided), but the stock is trading around $2.03 with a consensus analyst target of $2.75 (range $2.00–$3.50). With no dividends paid, shareholder returns depend largely on price recovery and any future reinvestment-to-growth turnaround."

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.